FI3883647T3 - C10-alkyleenisubstituoituja 13-jäsenisiä makrolidejä ja niiden käyttöjä - Google Patents

C10-alkyleenisubstituoituja 13-jäsenisiä makrolidejä ja niiden käyttöjä

Info

Publication number
FI3883647T3
FI3883647T3 FIEP19821351.4T FI19821351T FI3883647T3 FI 3883647 T3 FI3883647 T3 FI 3883647T3 FI 19821351 T FI19821351 T FI 19821351T FI 3883647 T3 FI3883647 T3 FI 3883647T3
Authority
FI
Finland
Prior art keywords
optionally substituted
group
optionally
alkyl
substituted
Prior art date
Application number
FIEP19821351.4T
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Roger B Clark
Richard Alm
Wesley Francis Austin
Philip Hogan
Ivan Jewett
Sushmita D Lahiri
Jonathan F Lawrence
Xiben Li
Shuhao Shi
Wenying Wang
Yoshitaka Ichikawa
Andrew G Myers
Ziyang Zhang
Peter Niels Carlsen
Andre Sanchez
Ganapathy Dhandapani
Thrimurtulu Neetipalli
Md Ataur Rahman
Thomas Lepitre
Original Assignee
Zikani Therapeutics Inc
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=68916562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI3883647(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zikani Therapeutics Inc, Harvard College filed Critical Zikani Therapeutics Inc
Application granted granted Critical
Publication of FI3883647T3 publication Critical patent/FI3883647T3/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FIEP19821351.4T 2018-11-19 2019-11-18 C10-alkyleenisubstituoituja 13-jäsenisiä makrolidejä ja niiden käyttöjä FI3883647T3 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862769383P 2018-11-19 2018-11-19
PCT/US2019/062030 WO2020106627A1 (en) 2018-11-19 2019-11-18 C10-alkylene substituted 13-membered macrolides and uses thereof

Publications (1)

Publication Number Publication Date
FI3883647T3 true FI3883647T3 (fi) 2026-03-25

Family

ID=68916562

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP19821351.4T FI3883647T3 (fi) 2018-11-19 2019-11-18 C10-alkyleenisubstituoituja 13-jäsenisiä makrolidejä ja niiden käyttöjä

Country Status (19)

Country Link
US (1) US12552825B2 (https=)
EP (2) EP4737470A2 (https=)
JP (2) JP7551610B2 (https=)
KR (1) KR102929869B1 (https=)
CN (1) CN113573779A (https=)
AU (1) AU2019385333B2 (https=)
BR (1) BR112021009624A2 (https=)
CA (1) CA3120148A1 (https=)
DK (1) DK3883647T3 (https=)
ES (1) ES3063764T3 (https=)
FI (1) FI3883647T3 (https=)
IL (1) IL283194B2 (https=)
LT (1) LT3883647T (https=)
MX (1) MX2021005423A (https=)
PT (1) PT3883647T (https=)
SG (1) SG11202105227QA (https=)
SI (1) SI3883647T1 (https=)
SM (1) SMT202600094T1 (https=)
WO (1) WO2020106627A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202313065A (zh) * 2021-05-28 2023-04-01 美商季卡尼醫療公司 用於治療遺傳疾病之化合物
WO2023250513A1 (en) * 2022-06-24 2023-12-28 Zikani Therapeutics, Inc. 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
CN120152721A (zh) 2022-09-01 2025-06-13 齐卡尼治疗股份有限公司 使用13元大环内酯治疗家族性腺瘤性息肉病

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
NZ526120A (en) * 1999-11-09 2005-02-25 Pfizer Prod Inc 13-membered azalides and their use as antibiotic agents
BR0110382A (pt) * 2000-04-27 2003-06-24 Pfizer Prod Inc Utilização de composições antibióticas azalida para o tratamento ou prevenção de uma infecção causada por bactérias ou protozoários em mamìferos
WO2003014136A1 (en) 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
HRP20030381B1 (en) * 2003-05-14 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
RU2008106915A (ru) * 2005-07-26 2009-09-10 Меркле Гмбх (De) Макролидные конъюгаты пирролиновых и индолизиновых соединений
US8097708B2 (en) * 2006-02-07 2012-01-17 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound
US20130102551A1 (en) * 2010-07-01 2013-04-25 Andreas Hotte Antibiotic compositions
WO2013004116A1 (zh) * 2011-07-06 2013-01-10 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
JP6437523B2 (ja) 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
CN106998685A (zh) 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
EP3273969A4 (en) * 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof
WO2016154533A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Synthesis of desosamines
US20180273573A1 (en) * 2015-10-01 2018-09-27 Memorial Sloan-Kettering Cancer Center Inhibitors of menaquinone biosynthesis
WO2018201076A2 (en) 2017-04-28 2018-11-01 Macrolide Pharmaceuticals Inc. Macrolides with modified desosamine sugars and uses thereof

Also Published As

Publication number Publication date
SG11202105227QA (en) 2021-06-29
DK3883647T3 (da) 2026-03-23
SI3883647T1 (sl) 2026-04-30
MX2021005423A (es) 2021-09-08
ES3063764T3 (en) 2026-04-20
IL283194A (en) 2021-06-30
IL283194B1 (en) 2024-11-01
PT3883647T (pt) 2026-02-26
EP3883647B1 (en) 2026-02-11
KR20210133950A (ko) 2021-11-08
JP2022507776A (ja) 2022-01-18
EP3883647A1 (en) 2021-09-29
IL283194B2 (en) 2025-03-01
SMT202600094T1 (it) 2026-03-09
US20230093692A1 (en) 2023-03-23
AU2019385333A1 (en) 2021-07-01
CN113573779A (zh) 2021-10-29
US12552825B2 (en) 2026-02-17
KR102929869B1 (ko) 2026-02-23
CA3120148A1 (en) 2020-05-28
AU2019385333B2 (en) 2025-04-17
LT3883647T (lt) 2026-03-25
EP4737470A2 (en) 2026-05-06
JP7551610B2 (ja) 2024-09-17
JP2025000636A (ja) 2025-01-07
BR112021009624A2 (pt) 2021-08-10
WO2020106627A1 (en) 2020-05-28

Similar Documents

Publication Publication Date Title
FI3883647T3 (fi) C10-alkyleenisubstituoituja 13-jäsenisiä makrolidejä ja niiden käyttöjä
HRP20241197T1 (hr) Makrociklični spojevi i primjene istih
TW200745034A (en) New compounds
CA2184919A1 (en) New Piperazine Derivatives and Methods for the Preparation Thereof and Compositions Containing the Same
WO2015104698A3 (en) Combination of novel nitrification inhibitors and biopesticides as well as combination of (thio)phosphoric acid triamides and biopesticides
RU2010116253A (ru) Производные n-гидроксилсульфонамида как новые физиологически применимые доноры нитроксила
TR200200749T2 (tr) Kinazolin bileşikleri ve bunları içeren farmasötik bileşikler.
RU2005120157A (ru) Хинолин-, изохинолин- и хиназолиноксиалкиламиды и их применение в качестве фунгицидов
JPH09227802A5 (https=)
EP2730604A3 (en) Functionalized caprolactone monomers useful for making poly(ethylene oxide)-block-poly(ester) block copolymers
NO20024906D0 (no) Antitumorale ekteinascidinderivater
MX2021003741A (es) Compuesto de heteroaril-azolo y agente de control de plagas.
HRP20251397T1 (hr) Spojevi koji inhibiraju kinazu ovisnu o ciklinu za liječenje medicinskih poremećaja
WO2014078295A8 (en) Gemcitabine prodrugs and uses thereof
PH12014500831A1 (en) 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives
HRPK20040293B3 (hr) Supstituirani benzimidazolski spojevi i njihova primjena u liječenju neoplazma
MX2021011286A (es) Compuestos de heterociclil(fenil)metanol útiles en el tratamiento de la hiperglucemia.
ES2081136T3 (es) 3-ureido-benzodiazepinonas utiles como antagonistas de cck o de gastrina.
CY1111936T1 (el) Ενωση κiνολονης και φαρμακευτικη συνθεση
ES2180201T3 (es) Derivados de azetidinona para el tratamiento de infecciones por hcmv.
RU2011149550A (ru) Соединения о-имино-изомочевины и их полимеризуемые композиции
WO2020128732A3 (en) Zwitterionic copolymers, coating compositions, articles, and coating methods
WO2010016606A3 (en) Hair growth regulating agent
WO2006040569A8 (en) Thiophene amide compounds for use in the treatment or prophylaxis of cancers
DK0625967T3 (da) N,N-substituerede imidocarbonimiddiamider deriveret af hydroxylaminer